Biotechnology company
Appears in 1 story
Developer of arcotatug tavatecan (IBI343)
Advanced gastric cancer that returns after treatment usually kills within about six months. On June 4, 2026, Chinese biotech Innovent Biologics said its drug had slowed that clock in a late-stage trial.
Updated 2 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
